WeInfuse and Trial IQ Partner to Integrate AI Clinical Research Tools for Infusion Providers

WeInfuse has announced a partnership with Trial IQ Technologies to integrate clinical research capabilities into infusion centers, according to a press release. The collaboration aims to help infusion providers launch and manage clinical trial programs using automation and AI tools.

The integration will allow WeInfuse users to access operational workflows and infrastructure that support clinical research within existing infusion operations. Trial IQ’s software automates trial matching, patient identification, site readiness, and physician education, enabling providers to become research ready with minimal disruption.

Through the partnership, infusion centers can embed research functions directly into their care environments, expanding access to clinical trials and new therapies. The combined platform is available to both current and future WeInfuse clients seeking to add clinical research services to their operations.